Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.

Characterization and clinical relevance of a new complement-fixing antibod-anti-m8-in patients with primary biliary cirrhosis

Abstract

A new complement-fixing antimitochondrial antibody-anti-M8-was detected in patients with primary biliary cirrhosis. Anti-M8 was only found in association with anti-M2, however, not all anti-M2 positive patients had anti-M8. Thus, among 66 anti-M2 positive patients, 29 were also positive for anti-M8, whereas sera from patients who had the complement-fixing anti-M2 and anti-M4 antibodies in parallel always strongly reacted with the M8 antigen. This group was previously described as mixed form. The M8 antigen was isolated either from human liver mitochondria or pig kidney microsomes and could be clearly distinguished from the M4 antigen. In contrast to M4, M8 was trypsin sensitive and banded at sucrose densities from 1.16 to 1.24, while M4 was found at densities from 1.08 to 1.14. Like M4, the M8 antigen also co-purified with outer mitochondrial membranes. Fifty-three patients with primary biliary cirrhosis have been followed over a period of up to 16 years and were classified according to their complement-fixing antimitochondrial antibody profile. At the time of the first diagnosis, 95% of 31 patients being anti-M2 positive, but anti-M8 negative (antimitochondrial antibody Profile I) were in Stage I or II. In contrast, only 61% of 13 patients being anti-M2 and anti-M8 positive (antimitochondrial antibody Profile II) and 44% of 9 patients with anti-M2, anti-M8 and anti-M4 in parallel (antimitochondrial antibody Profile III) belonged to Stage I or II. At the end of the observation period, only 24% of patients with antimitochondrial antibody Profile I (anti-M8 negative) had reached Stage III or IV, while 75% of patients with antimitochondrial antibody Profile II or III (anti-M8 positive) had a progression to Stage III or IV. It is concluded that the presence of complement-fixing anti-M8 antibody may herald a more progressive course of primary biliary cirrhosis.

Overview

Integrity signals

Registry

Crossref · 10.1002/hep.1840060402

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Research works printed but not linked: 11

  1. Berg, 1969, Clin Exp Immunol, 4, 511
  2. Meek, 1980, Clin Exp Immunol, 39, 599
  3. Lindenborn-Fotinos, 1982, Clin Exp Immunol, 50, 267
  4. Klein, 1984, Clin Exp Immunol, 58, 283
  5. Sayers, 1979, Clin Exp Immunol, 37, 68
  6. Labro, 1978, Clin Exp Immunol, 31, 357
  7. Homberg, 1982, Clin Exp Immunol, 47, 93
  8. Rizzetto, 1973, Clin Exp Immunol, 15, 331
  9. , . Glucose-6-phosphatase. In: ed. Meth der Enzymat Analyse. Weinheim/Bergstr.: Verlag Chemie, 1974: 909–913.
  10. . WHO handbook of immunological techniques. Geneva: World Health Organization, 1979.
  11. Miyachi, 1980, Clin Exp Immunol, 39, 599

Cited by

See all 50

Metadata

Authors
Weber, P., Brenner, J., Stechemesser, E., Klein, R., Weckenmann, U., Klöppel, G., Kirchhof, M., Fintelmann, V., & Berg, P. A.
Affiliations
Universität Hamburg (DE)
Venue
Hepatology
Published
1986-07
Volume
6
Issue
4
Pages
553-559
ISSN
0270-9139 (ISSN-L)
OpenAlex
W1990590661
Cited by
50
References
33
Citations by year
2025: 1 · 2022: 2
FWCI
8.34
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 10654 d)
Locations
  • Hepatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Dermatology › Autoimmune Bullous Skin Diseases
  • Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
Keywords
primary biliary cirrhosis, antimitochondrial antibodies, anti-M2 antibodies, complement-fixing antibodies, mitochondrial antigens, mitochondrial outer membrane, disease progression, prognosis, antibody profiles
MeSH terms
Antibodies, Antibody Specificity, Antigens, Centrifugation, Density Gradient, Chromatography, Gel, Complement System Proteins, Complement Fixation Tests, Electrophoresis, Polyacrylamide Gel, Enzymes, Follow-Up Studies, Immunodiffusion, Humans, Intracellular Membranes, Kidney, Liver Cirrhosis, Biliary, Mitochondria, Liver, Prognosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterization and clinical relevance of a new complement-fixing antibod-anti-m8-in patients with primary biliary cirrhosis. https://app.cochat.ai/papers/10.1002/hep.1840060402
The paper
Weber, P., Brenner, J., Stechemesser, E., Klein, R., Weckenmann, U., Klöppel, G., Kirchhof, M., Fintelmann, V., & Berg, P. A. (1986). Characterization and clinical relevance of a new complement-fixing antibod-anti-m8-in patients with primary biliary cirrhosis. Hepatology. https://doi.org/10.1002/hep.1840060402

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.